Germany's Wacker Chemie's Q3 core profit nearly doubles on cost cuts; keeps outlook

By Reuters News

- Wacker Chemie WCHG.DE on Thursday posted a higher third-quarter core profit, broadly in line with expectations, helped by cost-cutting measures, higher selling prices and a one-off gain in its polysilicon business, while maintaining its full-year sales and earnings forecast.

The German specialty chemicals maker said earnings before interest, taxes, depreciation and amortisation (EBITDA) nearly doubled to €217.2 million ($242.4 million) in the July-September period from €111.7 million a year earlier.

Analysts polled by Vara Research forecast third-quarter EBITDA of €213 million.

Chief Executive Christian Hartel credited a cost-savings and efficiency program launched in October 2025, known as PACE, for the improvement.

"Our quarterly results show that the cost-savings and efficiency measures we introduced a year ago are having an impact," he said, while adding that the economic environment remains challenging.

Group sales rose 9.4% year-on-year to €1.47 billion, driven by higher volumes and selling prices, as all four business divisions beat their prior-year sales levels.

Silicones increased sales by 8% on-year to €729 million, while polymers revenue rose 11% to €381 million. Biosolutions sales gained 8% to €100 million, while polysilicon revenue jumped 14% to €225 million.

Wacker Chemie, whose hyperpure polysilicon is used to make silicon wafers for chips in artificial intelligence, high‑performance computing and microelectronics, noted that while the solar-grade polysilicon business remained challenging, the semiconductor-grade polysilicon business continued to perform well.

The group also said about €35 million of quarterly EBITDA came from the termination of a contract in its polysilicon division.

($1 = 0.8959 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.